Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
277 studies found for:    "Expanded Access" [STUDY-TYPES]
Show Display Options
Download search resultsDownload the search results for:
"Expanded Access" [STUDY-TYPES] (277 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Available Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Condition: Unresected Stage IIIb to IVM1c Melanoma
Intervention: Drug: Talimogene Laherparepvec
2 Unknown  Using Hypnotherapy For Dementia & Alzheimer's
Condition: Alzheimer Disease
Intervention: Other: Hypnotherapy
3 No longer available Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
Conditions: Metastatic Liver Cancer;   Ocular Melanoma;   Cutaneous Melanoma
Interventions: Drug: Melphalan;   Device: Percutaneous Hepatic Perfusion
4 Temporarily not available An Open-Label Treatment Protocol With UX003 rhGUS Enzyme Replacement Therapy for an Advanced Stage MPS 7 Patient
Condition: Mucopolysaccharidosis Type 7
Intervention: Drug: UX003
5 Temporarily not available 99m-Technetium- Glucosamine in Arthritis
Conditions: Rheumatoid Arthritis;   Ankylosing Spondylitis
Intervention: Device: Technetium labelled glucosamine
6 Temporarily not available Pulmonary Vein Isolation Outcomes With Fish Oils
Condition: Atrial Fibrillation
Intervention: Drug: Lovaza (Fish Oils)
7 Available Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)
Conditions: EBV Infection;   CMV Infection;   Adenoviral Infection
Intervention: Biological: Trivirus-Specific CTLs
8 Approved for marketing Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Infantile-onset Pompe Disease
Conditions: Glycogen Storage Disease Type II;   Glycogenosis 2
Intervention: Biological: alglucosidase alfa
9 Available Compassionate Use of Dolutegravir and Ibalizumab for the Treatment of HIV Infection
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: Dolutegravir;   Drug: Ibalizumab
10 Available 131-I-MIBG Therapy for Refractory Neuroblastoma and Metastatic Pheochromocytoma
Conditions: Neuroblastoma;   Childhood Metastatic Pheochromocytoma
Interventions: Drug: 131 I-Metaiodobenzylguanidine (131 I-MIBG);   Drug: 131 I-MIBG
11 No longer available Emergency/Compassionate Use - AMPLATZER Duct Occluder
Conditions: Patent;   Ductus;   Arteriosus
Intervention: Device: Device closure with the AMPLATZER Duct Occluder
12 Approved for marketing Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)
Condition: Cancer
Intervention: Drug: Denileukin diftitox (ONTAK)
13 No longer available Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: sildenafil (Revatio) 20 mg TID
14 Temporarily not available Improvement of Myocardial Blood Flow by PhosphoDiesterase 5 Inhibition in Coronary Artery Disease
Conditions: Therapy Refractory Myocardial Ischemia;   Coronary Artery Disease;   Unsuitable for Surgical or Percutaneous Revascularisation
Interventions: Drug: Vardenafil;   Other: Placebo
15 No longer available Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection
Conditions: Infection;   Precancerous/Nonmalignant Condition
Interventions: Biological: therapeutic allogeneic lymphocytes;   Procedure: allogeneic bone marrow transplantation;   Radiation: total-body irradiation
16 Available Expanded Access Program With Nivolumab (BMS-936558) in Combination With Ipilimumab (Yervoy®) in Anti-CTLA-4 Treatment-Naïve Subjects With Unresectable or Metastatic Melanoma (CheckMate 218)
Condition: Malignant Melanoma
Interventions: Drug: Nivolumab;   Drug: Ipilimumab
17 Unknown  To Evaluate Oral Phase Swallowing Function Using Submental Ultrasound
Condition: Dysphagia
Intervention: Procedure: Ultrasound
18 Unknown  Prospective Analysis and Comparison of Stress Echo to Real-Time Myocardial Contrast Stress Echo
Condition: Evaluation of Troponin I Levels
Intervention: Other: Dobutamine: Perflutren Lipid Microsphere
19 Approved for marketing A Phase III Second Line Trial in Advanced Pancreatic Cancer CONKO 003
Condition: Pancreatic Cancer
Intervention: Drug: OFF in experimental arm
20 Unknown  Effect of Genes on Rosuvastatin Therapy for Hyperlipidemia
Condition: Hyperlipidemia
Interventions: Drug: rosuvastatin,fenofibrate;   Genetic: CYP2C9, UGT1A1, UGT1A3, OATP2, BCRP

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years